Global RWE Oncology Market By Component (Real-world Datasets (EMR/EHR/Clinical Data, Administrative Claims & Billing Data, Pharmacy Data, Cancer Registries, Specialty Data Providers, Others) Real-world Consulting & Analytics Services) By Application (Clinical Trials, Drug Development and Approvals, Post marketing Safety Studies, Market Access and Reimbursement, Medical Device Development, Others) By End Users (Biotechnology Companies, Medical Device Companies, Healthcare Payers, Healthcare Providers, Others) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031